協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/02 | 2,863 | 2,928 | 2,863 | 2,919 | +65 | +2.3% | 657,800 |
| 2022/02/01 | 2,874 | 2,908 | 2,844 | 2,854 | -1 | ±0% | 725,900 |
| 2022/01/31 | 2,880 | 2,880 | 2,836 | 2,855 | -10 | -0.3% | 1,029,500 |
| 2022/01/28 | 2,865 | 2,904 | 2,852 | 2,865 | +28 | +1% | 756,500 |
| 2022/01/27 | 2,907 | 2,908 | 2,817 | 2,837 | -72 | -2.5% | 912,400 |
| 2022/01/26 | 2,918 | 2,942 | 2,889 | 2,909 | -1 | ±0% | 532,200 |
| 2022/01/25 | 2,901 | 2,931 | 2,887 | 2,910 | -41 | -1.4% | 1,282,000 |
| 2022/01/24 | 2,907 | 2,964 | 2,894 | 2,951 | +35 | +1.2% | 624,600 |
| 2022/01/21 | 2,893 | 2,929 | 2,844 | 2,916 | -9 | -0.3% | 708,400 |
| 2022/01/20 | 2,844 | 2,957 | 2,844 | 2,925 | +86 | +3% | 1,026,900 |
| 2022/01/19 | 2,889 | 2,913 | 2,826 | 2,839 | -84 | -2.9% | 805,400 |
| 2022/01/18 | 2,966 | 2,985 | 2,920 | 2,923 | -43 | -1.4% | 517,400 |
| 2022/01/17 | 2,954 | 3,005 | 2,943 | 2,966 | +28 | +1% | 638,200 |
| 2022/01/14 | 2,950 | 2,950 | 2,909 | 2,938 | -102 | -3.4% | 1,302,100 |
| 2022/01/13 | 3,095 | 3,110 | 3,030 | 3,040 | -100 | -3.2% | 746,700 |
| 2022/01/12 | 3,095 | 3,170 | 3,080 | 3,140 | +50 | +1.6% | 765,800 |
| 2022/01/11 | 3,015 | 3,105 | 3,000 | 3,090 | +25 | +0.8% | 1,077,800 |
| 2022/01/07 | 3,090 | 3,110 | 3,045 | 3,065 | -25 | -0.8% | 919,500 |
| 2022/01/06 | 3,175 | 3,185 | 3,090 | 3,090 | -105 | -3.3% | 819,900 |
| 2022/01/05 | 3,185 | 3,205 | 3,150 | 3,195 | +5 | +0.2% | 497,300 |
| 2022/01/04 | 3,200 | 3,200 | 3,155 | 3,190 | +55 | +1.8% | 439,200 |
| 2021/12/30 | 3,145 | 3,175 | 3,125 | 3,135 | -25 | -0.8% | 458,700 |
| 2021/12/29 | 3,165 | 3,200 | 3,135 | 3,160 | -55 | -1.7% | 420,800 |
| 2021/12/28 | 3,200 | 3,225 | 3,190 | 3,215 | +30 | +0.9% | 457,900 |
| 2021/12/27 | 3,200 | 3,205 | 3,170 | 3,185 | -20 | -0.6% | 309,600 |
| 2021/12/24 | 3,225 | 3,235 | 3,195 | 3,205 | -15 | -0.5% | 245,000 |
| 2021/12/23 | 3,210 | 3,230 | 3,185 | 3,220 | +20 | +0.6% | 318,500 |
| 2021/12/22 | 3,215 | 3,220 | 3,180 | 3,200 | -10 | -0.3% | 374,900 |
| 2021/12/21 | 3,170 | 3,230 | 3,170 | 3,210 | +50 | +1.6% | 484,900 |
| 2021/12/20 | 3,150 | 3,200 | 3,145 | 3,160 | -45 | -1.4% | 459,900 |
| 2021/12/17 | 3,250 | 3,270 | 3,185 | 3,205 | -85 | -2.6% | 930,300 |
| 2021/12/16 | 3,340 | 3,340 | 3,235 | 3,290 | +90 | +2.8% | 594,700 |
| 2021/12/15 | 3,190 | 3,240 | 3,180 | 3,200 | -20 | -0.6% | 585,100 |
| 2021/12/14 | 3,205 | 3,265 | 3,190 | 3,220 | ±0 | ±0% | 717,800 |
| 2021/12/13 | 3,250 | 3,260 | 3,220 | 3,220 | +15 | +0.5% | 490,000 |
| 2021/12/10 | 3,225 | 3,270 | 3,190 | 3,205 | -45 | -1.4% | 916,300 |
| 2021/12/09 | 3,305 | 3,330 | 3,230 | 3,250 | -35 | -1.1% | 812,900 |
| 2021/12/08 | 3,270 | 3,295 | 3,250 | 3,285 | +25 | +0.8% | 786,900 |
| 2021/12/07 | 3,250 | 3,275 | 3,155 | 3,260 | ±0 | ±0% | 1,416,300 |
| 2021/12/06 | 3,275 | 3,295 | 3,250 | 3,260 | -20 | -0.6% | 577,800 |
| 2021/12/03 | 3,265 | 3,295 | 3,225 | 3,280 | +15 | +0.5% | 635,100 |
| 2021/12/02 | 3,185 | 3,295 | 3,180 | 3,265 | +30 | +0.9% | 1,130,600 |
| 2021/12/01 | 3,170 | 3,255 | 3,135 | 3,235 | +65 | +2.1% | 1,164,600 |
| 2021/11/30 | 3,270 | 3,305 | 3,160 | 3,170 | -85 | -2.6% | 1,701,100 |
| 2021/11/29 | 3,285 | 3,305 | 3,240 | 3,255 | -85 | -2.5% | 850,200 |
| 2021/11/26 | 3,395 | 3,410 | 3,320 | 3,340 | -85 | -2.5% | 951,000 |
| 2021/11/25 | 3,375 | 3,435 | 3,340 | 3,425 | +50 | +1.5% | 683,400 |
| 2021/11/24 | 3,400 | 3,415 | 3,340 | 3,375 | ±0 | ±0% | 843,800 |
| 2021/11/22 | 3,275 | 3,380 | 3,215 | 3,375 | +55 | +1.7% | 1,220,600 |
| 2021/11/19 | 3,370 | 3,370 | 3,295 | 3,320 | -75 | -2.2% | 1,312,100 |
801～
850
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
